Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (80779)	10/15/1999 6:56:00 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

>>Bought MLNM @ 67 5/8 << Why! Other than they came in with losses under expectations. >> Cambridge, Massachusetts, Oct. 15 (Bloomberg) -- Millennium Pharmaceuticals Inc. shares fell 25 percent after the biotech company agreed to buy LeukoSite Inc., a money-losing competitor, for about $635 million in stock. Shares of Millennium, which hasn't brought a drug to market or tested one on people, fell 21 7/32 to close at 62 1/4. That's the largest one-day drop since Millennium went public in May 1996 and it shaved more than $750 million off the company's market value. << >>Loss from operations (6,998) (10,340) (10,629) (24,715)<<